Jun 24, 2008
Editorial: Risky de-risking
Has Malvinder Singh truly freed Ranbaxy from risk by opting for an out-of-court settlement with Pfizer over Lipitor as he has claimed? The markets and analysts certainly thought otherwise.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Ask Dr. Gott (from Sep '06) | 3 hr | Linda | 415 |
| Cholesterol drug linked to amnesia | Sep 30 | jim pierce | 1 |
| Do statins harm immune system? | Sep 30 | Ridge | 1 |
| Splitting pills saves money, but irritates drug... (from Feb '06) | Sep 29 | Steve | 21 |
| Lawsuits filed over Lipitor side effects (from Jun '06) | Sep 25 | Joe Donner | 481 |
| What can my husband do for TGA? | Sep 13 | Fran | 4 |
| Drug Ads Losing Recall Effectiveness Among Cons... | Sep '08 | Jack50 | 1 |
